VASODILATORY SHOCK
Clinical trials for VASODILATORY SHOCK explained in plain language.
Never miss a new study
Get alerted when new VASODILATORY SHOCK trials appear
Sign up with your email to follow new studies for VASODILATORY SHOCK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids in shock: drug trial targets stubborn low blood pressure
Disease control ENROLLING_BY_INVITATIONThis study tests a drug called Angiotensin II (Giapreza) in 30 children under 18 with life-threatening low blood pressure (vasodilatory shock) that hasn't improved with fluids or standard medicines. The goal is to see if the drug can safely raise blood pressure and reduce the nee…
Matched conditions: VASODILATORY SHOCK
Phase: PHASE4 • Sponsor: Todd Sweberg • Aim: Disease control
Last updated May 18, 2026 11:59 UTC
-
Could a new drug save liver patients from deadly shock?
Disease control OngoingThis study compares a drug called Angiotensin II to the usual treatment for raising blood pressure in people with liver disease who have a dangerous drop in blood pressure (shock). The goal is to see if Angiotensin II helps the heart and blood vessels work together better. About …
Matched conditions: VASODILATORY SHOCK
Phase: EARLY_PHASE1 • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated May 12, 2026 13:40 UTC